Healthcare - Biotechnology - NASDAQ - US
$ 1.04
8.64 %
$ 45.7 M
Market Cap
-0.67
P/E
BALANCE SHEET
60.9 M
ASSETS
24.1 M
LIABILITIES
36.8 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Xilio Therapeutics, Inc.
| Current Assets | 48.1 M |
| Cash & Short-Term Investments | 44.7 M |
| Receivables | 0 |
| Other Current Assets | 3.42 M |
| Non-Current Assets | 12.8 M |
| Long-Term Investments | 0 |
| PP&E | 11.2 M |
| Other Non-Current Assets | 1.6 M |
| Current Liabilities | 16 M |
| Accounts Payable | 1.05 M |
| Short-Term Debt | 1.05 M |
| Other Current Liabilities | 13.9 M |
| Non-Current Liabilities | 8.14 M |
| Long-Term Debt | 16.3 M |
| Other Non-Current Liabilities | -8.14 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 44.7 | 120.4 | 198.1 | 19.2 | 48.8 |
| Short Term Investments | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 3.4 | 8.2 | 8.9 | 1.4 | 2.3 |
| Total Current Assets | 48.1 | 124.5 | 202.5 | 20.6 | 51.1 |
| PP&E | 11.2 | 12.8 | 13.6 | 13.7 | 9.9 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 1.6 | 1.6 | 1.6 | 0.2 |
| Other Long Term Assets | 1.6 | 0.3 | 1.9 | 0.5 | 1.6 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 60.9 | 139.2 | 218.1 | 36.3 | 62.7 |
| LIABILITIES | |||||
| Accounts Payable | 1.1 | 3.1 | 3.1 | 5.4 | 2.5 |
| Short Term Debt | 1.0 | 7.6 | 0.8 | 2.9 | 0 |
| Other Current Liabilities | 13.9 | 10.4 | 8.8 | 13.8 | 2.7 |
| Total Current Liabilities | 16.0 | 21.1 | 12.8 | 22.2 | 5.2 |
| Long Term Debt | 16.3 | 12.4 | 19.7 | 18.3 | 18.6 |
| Deferred Tax Income | 0 | 0 | 3.5 | 0 | 0 |
| Other Liabilities | (8.1) | 45 K | 0.1 | 79.1 | 68.4 |
| Total Liabilities | 24.1 | 33.5 | 32.6 | 119.6 | 92.2 |
| EQUITY | |||||
| Common Stock | 3 K | 3 K | 3 K | 1 K | 0 |
| Retained Earnings | (325.5) | (249.1) | (160.9) | (85.1) | (29.9) |
| Other Accumulative Comprehensive Income/Loss | 0 | 0 | (218.1) | (78.0) | 0 |
| Total Equity | 36.8 | 105.6 | 185.4 | (83.3) | (29.5) |
| Total Liabilities and Equity | 60.9 | 139.2 | 218.1 | 36.3 | 62.7 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 27.5 | 27.4 | 27.4 | 27.5 | 27 468.9 |